
Alcon Inc. – NYSE:ALC
Alcon stock price today
Alcon stock price monthly change
Alcon stock price quarterly change
Alcon stock price yearly change
Alcon key metrics
Market Cap | 41.80B |
Enterprise value | 40.68B |
P/E | 36.48 |
EV/Sales | 4.10 |
EV/EBITDA | 18.54 |
Price/Sales | 4.26 |
Price/Book | N/A |
PEG ratio | -2.98 |
EPS | 2.15 |
Revenue | 9.68B |
EBITDA | 2.00B |
Income | 1.04B |
Revenue Q/Q | 4.54% |
Revenue Y/Y | 9.10% |
Profit margin | 11.72% |
Oper. margin | 14.87% |
Gross margin | 55.42% |
EBIT margin | 14.87% |
EBITDA margin | 20.69% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAlcon stock price history
Alcon stock forecast
Alcon financial statements
$107.8
Potential upside: 28.34%
Analysts Price target
Financials & Ratios estimates
Jun 2023 | 2.42B | 169M | 6.98% |
---|---|---|---|
Sep 2023 | 2.32B | 204M | 8.76% |
Dec 2023 | 2.47B | 427M | 17.23% |
Mar 2024 | 2.45B | 248M | 10.09% |
2023-02-27 | 0.42 | 0.42 |
---|---|---|
2023-05-09 | 0.6 | 0.7 |
2023-08-15 | 0.62 | 0.69 |
Payout ratio | 11.41% |
---|
2019 | |
---|---|
2020 | |
2021 | 0.13% |
2022 | 0.31% |
2023 | 0.3% |
Jun 2023 | 29181416626 | 9.26B | 31.74% |
---|---|---|---|
Sep 2023 | 29346563258 | 9.20B | 31.38% |
Dec 2023 | 29603971840 | 8.98B | 30.36% |
Mar 2024 | 29565000000 | 8.73B | 29.56% |
Jun 2023 | 323.72M | -410.00M | -144.92M |
---|---|---|---|
Sep 2023 | 501.71M | -137.16M | 12.43M |
Dec 2023 | 479.37M | -397.27M | -58.64M |
Mar 2024 | 341M | -218M | -66M |
Alcon alternative data
Aug 2023 | 25,000 |
---|---|
Sep 2023 | 25,000 |
Oct 2023 | 25,000 |
Nov 2023 | 25,000 |
Dec 2023 | 25,000 |
Jan 2024 | 25,000 |
Feb 2024 | 25,000 |
Mar 2024 | 25,315 |
Apr 2024 | 25,315 |
May 2024 | 25,315 |
Jun 2024 | 25,000 |
Jul 2024 | 25,000 |
Alcon other data
Patent |
---|
Grant Filling date: 13 Apr 2021 Issue date: 20 Sep 2022 |
Grant Utility: Angle adjustment system Filling date: 14 Feb 2020 Issue date: 20 Sep 2022 |
Grant Filling date: 11 Apr 2019 Issue date: 20 Sep 2022 |
Grant Utility: Ophthalmic compositions Filling date: 25 Jun 2020 Issue date: 13 Sep 2022 |
Grant Utility: Valve cooling and noise suppression Filling date: 9 Apr 2020 Issue date: 13 Sep 2022 |
Grant Filling date: 12 Dec 2019 Issue date: 13 Sep 2022 |
Grant Utility: Intraocular lens injector Filling date: 10 Jul 2019 Issue date: 13 Sep 2022 |
Application Filling date: 23 May 2022 Issue date: 8 Sep 2022 |
Application Filling date: 23 May 2022 Issue date: 8 Sep 2022 |
Application Filling date: 7 Mar 2022 Issue date: 8 Sep 2022 |
Quarter | Transcript |
---|---|
Q1 2024 14 May 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 28 Feb 2024 | Q4 2023 Earnings Call Transcript |
Q3 2023 15 Nov 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 16 Aug 2023 | Q2 2023 Earnings Call Transcript |
Insider | Compensation |
---|---|
Mr. David J. Endicott (1965) Chief Executive Officer & Director | $3,120,000 |
Mr. F. Michael Ball (1955) Executive Chairman | $316,280 |
Mr. Arthur B. Cummings M.D. (1962) Executive Director | $216,660 |
Alcon: Buy An Eyecare Leader With $2 Billion In Quarterly Sales
Alcon: Lackluster Growth Given Its Valuation
Alcon: The Steady Force Of 'Boring'
National Vision Holdings: Keep An Eye On This One
Bausch + Lomb: Brent Saunders Return Bodes Well For Shareholders
Alcon: Case Of Growth Destructive To Value, Reiterate Hold At 24x Earnings
Alcon: Eyeing A Growth Story That Could Benefit From A Weaker Dollar
Alcon: Looking To Break Downtrend Before Entry
The Rise Of Investable Public Benefit Corporations
-
What's the price of Alcon stock today?
One share of Alcon stock can currently be purchased for approximately $83.99.
-
When is Alcon's next earnings date?
Unfortunately, Alcon's (ALC) next earnings date is currently unknown.
-
Does Alcon pay dividends?
Yes, Alcon pays dividends and its trailing 12-month yield is 0.31% with 11% payout ratio. The last Alcon stock dividend of $0.1 was paid on 5 Sep 2025.
-
How much money does Alcon make?
Alcon has a market capitalization of 41.80B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 8.47% to 9.46B US dollars. Alcon earned 974M US dollars in net income (profit) last year or $0.69 on an earnings per share basis.
-
What is Alcon's stock symbol?
Alcon Inc. is traded on the NYSE under the ticker symbol "ALC".
-
What is Alcon's primary industry?
Company operates in the Healthcare sector and Medical - Instruments & Supplies industry.
-
How do i buy shares of Alcon?
Shares of Alcon can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Alcon's key executives?
Alcon's management team includes the following people:
- Mr. David J. Endicott Chief Executive Officer & Director(age: 60, pay: $3,120,000)
- Mr. F. Michael Ball Executive Chairman(age: 70, pay: $316,280)
- Mr. Arthur B. Cummings M.D. Executive Director(age: 63, pay: $216,660)
-
How many employees does Alcon have?
As Jul 2024, Alcon employs 25,000 workers, which is 1% less then previous quarter.
-
When Alcon went public?
Alcon Inc. is publicly traded company for more then 6 years since IPO on 9 Apr 2019.
-
What is Alcon's official website?
The official website for Alcon is alcon.com.
-
How can i contact Alcon?
Alcon can be reached via phone at +41 58 911 20 00.
-
What is Alcon stock forecast & price target?
Based on 5 Wall Street analysts` predicted price targets for Alcon in the last 12 months, the avarage price target is $107.8. The average price target represents a 28.34% change from the last price of $83.99.
Alcon company profile:

Alcon Inc.
alcon.comNYSE
25,000
Medical - Instruments & Supplies
Healthcare
Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under the PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Geneva, 1214
CIK: 0001167379
ISIN: CH0432492467
CUSIP: H01301128